Prosoria – A New Non-Prescription Treatment System For Psoriasis Symptoms – Now On-Sale Online For First Time
FT. WORTH, TX, Feb. 13, 2018 – Prosoria™, a new non-prescription treatment for relieving and helping prevent the symptoms of psoriasis, is now available for sale to the public for the first time. Prosoria™ is available to purchase online at https://prosoria.com as well as on amazon.com.
“There is a huge need for Prosoria,” explained Art Clapp, CEO of Nuvothera Inc. which manufactures Prosoria™. “Psoriasis is the world’s largest autoimmune disease, affecting more than eight million people in the U.S. and 125 million worldwide. Yet research shows that 87.8 percent of patients and 98.0 percent of dermatologists feel there is a strong or moderate need for better psoriasis therapies.
“Prosoria is the first once daily, three-step psoriasis treatment system proven to effectively relieve the symptoms of psoriasis and help prevent recurrences,” Clapp said. “Its safety and effectiveness was recently recognized by the National Psoriasis Foundation’s prestigious Seal of Recognition.”
“In addition to the medical challenges, psoriasis can also have a significant psychosocial impact on the lives of people living with the condition,” said Clapp. “We have heard personal stories from people who were afraid to wear shorts or expose their skin or experienced rejection from employers for jobs and in relationships. Their self-esteem and confidence are often affected.”
Karl Woolfenden of Dallas, TX, an early test user, said that compared to other treatments, Prosoria™ “was amazing. With this product, I tried it, I saw results. I didn’t have any side effects. It was easy to use, easy to apply. I would say I had about 25 percent coverage, mainly on my legs, my knees and my elbows. Since using the product that has completely reduced down. I would say now I’m about 2 percent covered. So with a little bit more time, I feel I’ll be 100 percent free.”
Vickie Wilkerson of Shreveport, LA, said Prosoria™ began working for her right away. “It was immediate. Within a couple of days, I could tell a difference. You get these big red raised areas and to see them being like normal skin, like at a normal level – that was amazing…. I was floored because it was the first thing that actually worked for me in 14 years.”
See and hear how other users have benefited from Prosoria™, on the company website https://prosoria.com/results/.
“Prosoria combines both clinical strength and natural pro-botanical ingredients that help relieve psoriasis symptoms while softening and restoring the appearance of skin,” said Bev Hope, Nuvothera Marketing Director. “The products were formulated to feel light and silky on the skin. They are steroid free, fragrance free, and paraben free, and they are safe and gentle to use every day.
The treatment system consists of four products. It includes three pump bottles of gels and a cream for the daily system plus a tube of Prosoria™ Rapid Repair Exfoliating Ointment for more intensive night care, Hope said. The Prosoria™ Daily Psoriasis Treatment System was designed to:
- Hydrate and condition affected skin
- Treat and relieve scaling, flaking, itching, redness, irritation
- Moisturize and exfoliate the skin, leaving it feeling softer and smoother
- Restore the appearance of skin and improve skin texture
To learn more about the new Prosoria™ Daily Psoriasis Treatment System, visit https://prosoria.com/.
Founded in 2014 and based in Ft. Worth, TX, Nuvothera was formed with the mission to develop novel OTC products for difficult-to-treat skin diseases such as psoriasis, incorporating natural botanical ingredients and using the latest in scientific knowledge and evidence-based research. The company’s primary focus is psoriasis. The management team consists of seasoned dermatology pharmaceutical executives committed to meeting the needs of the individual having psoriasis and partnering with the psoriasis community. Both dermatologists (MDs) and scientists (PhDs) were involved in developing Prosoria™. Prosoria™ products are dermatology and clinically tested.